Drug Type siRNA |
Synonyms |
Target |
Action inhibitors |
Mechanism HTATIP2 inhibitors(HIV-1 Tat interactive protein 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Disorder of Complement | Preclinical | China | 24 Aug 2023 |